Company Profile

Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of drugs in the areas of infection, cancer and respiratory disease. The Company’s lead product candidate, cethromycin, is a novel once-a-day antibiotic developed for the treatment of respiratory tract infections.

Advanced Life Sciences has assembled a promising pipeline of clinical and preclinical candidates using its internal discovery platform of natural product optimization through medicinal chemistry and structural biology, coupled with in-licensing promising new products. The Company has three product candidates that are either in clinical development or approved to begin clinical development, as well as six additional candidates in preclinical development.

Advanced Life Sciences is focusing its resources on the development and commercialization of cethromycin for use in respiratory tract infections such as community acquired pneumonia, bronchitis and sinusitis. The Company recently announced the completion of its two pivotal phase III clinical trials in community acquired pneumonia in which cethromycin achieved its primary endpoint of demonstrating non-inferiority compared to the current standard of care. Advanced Life Sciences plans to partner with other organizations to advance its earlier stage programs.